Johnson & Johnson
Latest statistics and disclosures from Johnson & Johnson's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PTGX, NBTX, MGTX, RAPP, CTNM, and represent 89.26% of Johnson & Johnson's stock portfolio.
- Added to shares of these 1 stock: CBRS (+$13M).
- Johnson & Johnson was a net buyer of stock by $13M.
- Johnson & Johnson has $762M in assets under management (AUM), dropping by -4.63%.
- Central Index Key (CIK): 0000200406
Tip: Access up to 7 years of quarterly data
Positions held by Johnson & Johnson consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 15 positions in its portfolio as reported in the September 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 45.3 | $345M | 2.4M | 140.89 |
|
|
| Nanobiotix Sponsored Ads (NBTX) | 23.0 | $175M | 5.6M | 31.16 |
|
|
| Meiragtx Holdings (MGTX) | 9.6 | $73M | 6.6M | 11.00 |
|
|
| Rapport Therapeutics (RAPP) | 7.9 | $60M | 1.8M | 33.60 |
|
|
| Contineum Therapeutics Cl A (CTNM) | 3.5 | $27M | 2.0M | 13.42 |
|
|
| Cerebras Systems Com Cl A (CBRS) | 3.0 | $23M | +140% | 129k | 177.65 |
|
| Xencor (XNCR) | 2.5 | $19M | 748k | 24.95 |
|
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.1 | $16M | 815k | 19.89 |
|
|
| Fate Therapeutics (FATE) | 1.1 | $8.0M | 3.4M | 2.37 |
|
|
| CVRX (CVRX) | 0.9 | $7.0M | 4.0M | 1.75 |
|
|
| Procept Biorobotics Corp (PRCT) | 0.9 | $6.5M | 358k | 18.22 |
|
|
| Neumora Therapeutics (NMRA) | 0.1 | $1.1M | 1.8M | 0.60 |
|
|
| Vor Biopharma Com New (VOR) | 0.1 | $1.0M | 54k | 19.08 |
|
|
| D Fluidigm Corp Del (LAB) | 0.0 | $231k | 312k | 0.74 |
|
|
| Adicet Bio Com New (ACET) | 0.0 | $163k | 23k | 7.14 |
|
Past Filings by Johnson & Johnson
SEC 13F filings are viewable for Johnson & Johnson going back to 2021
- Johnson & Johnson 2026 Q3 filed Oct. 26, 2026
- Johnson & Johnson 2026 Q2 filed Aug. 6, 2026
- Johnson & Johnson 2026 Q1 filed May 13, 2026
- Johnson & Johnson 2025 Q3 restated filed March 18, 2026
- Johnson & Johnson 2025 Q4 restated filed March 18, 2026
- Johnson & Johnson 2025 Q4 filed Feb. 13, 2026
- Johnson & Johnson 2025 Q3 filed Nov. 13, 2025
- Johnson & Johnson 2025 Q2 filed July 22, 2025
- Johnson & Johnson 2025 Q1 filed May 7, 2025
- Johnson & Johnson 2024 Q4 filed Feb. 13, 2025
- Johnson & Johnson 2024 Q3 filed Nov. 13, 2024
- Johnson & Johnson 2024 Q2 filed Aug. 9, 2024
- Johnson & Johnson 2024 Q1 filed May 10, 2024
- Johnson & Johnson 2023 Q3 filed Nov. 9, 2023
- Johnson & Johnson 2023 Q2 filed Aug. 2, 2023
- Johnson & Johnson 2023 Q1 filed May 11, 2023